PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-03

Date Title Company
03-Sep-2023 Rallybio Presents Phase 1 Single Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 Businesswire